Research ArticleOriginal Research

Reproducibility of the Sputum Color Evaluation Depends on the Category of Caregivers

Gregory Reychler, Emmanuel Andre, Laurence Couturiaux, Kinga Hohenwarter, Giuseppe Liistro, Thierry Pieters and Annie Robert
Respiratory Care July 2016, 61 (7) 936-942; DOI: https://doi.org/10.4187/respcare.04547

References

  1. 1.↵
    1. King PT,
    2. Holdsworth SR,
    3. Freezer NJ,
    4. Villanueva E,
    5. Holmes PW
    . Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med 2006;100(12):2183–2189.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Mullen JB,
    2. Wright JL,
    3. Wiggs BR,
    4. Paré PD,
    5. Hogg JC
    . Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: relationship to lung function. Thorax 1987;42(11):843–848.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Stănescu D,
    2. Sanna A,
    3. Veriter C,
    4. Kostianev S,
    5. Calcagni PG,
    6. Fabbri LM,
    7. Maestrelli P
    . Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996;51(3):267–271.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Lange P,
    2. Nyboe J,
    3. Appleyard M,
    4. Jensen G,
    5. Schnohr P
    . Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990;45(8):579–585.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Murray MP,
    2. Pentland JL,
    3. Turnbull K,
    4. MacQuarrie S,
    5. Hill AT
    . Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis. Eur Respir J 2009;34(2):361–364.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Stockley RA,
    2. O'Brien C,
    3. Pye A,
    4. Hill SL
    . Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000;117(6):1638–1645.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Anthonisen NR,
    2. Manfreda J,
    3. Warren CP,
    4. Hershfield ES,
    5. Harding GK,
    6. Nelson NA
    . Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106(2):196–204.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Brusse-Keizer MG,
    2. Grotenhuis AJ,
    3. Kerstjens HA,
    4. Telgen MC,
    5. van der Palen J,
    6. Hendrix MG,
    7. van der Valk PD
    . Relation of sputum colour to bacterial load in acute exacerbations of COPD. Respir Med 2009;103(4):601–606.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Soler-Cataluña JJ,
    2. Alcázar-Navarrete B,
    3. Miravitlles M
    . The concept of control of COPD in clinical practice. Int J Chron Obstruct Pulmon Dis 2014;9:1397–1405.
    OpenUrlPubMed
  10. 10.↵
    1. Daniels JM,
    2. de Graaff CS,
    3. Vlaspolder F,
    4. Snijders D,
    5. Jansen HM,
    6. Boersma WG
    . Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease. Clin Microbiol Infect 2010;16(6):583–588.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Terwee CB,
    2. Bot SD,
    3. de Boer MR,
    4. van der Windt DA,
    5. Knol DL,
    6. Dekker J,
    7. et al
    . Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60(1):34–42.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Soeken KL,
    2. Prescott PA
    . Issues in the use of kappa to estimate reliability. Med Care 1986;24(8):733–741.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Altman DG
    . Practical statistics for medical research. London: Chapman and Hall; 1991;179–276.
  14. 14.↵
    1. Diego AD,
    2. Milara J,
    3. Martinez-Moragón E,
    4. Palop M,
    5. León M,
    6. Cortijo J
    . Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis. Respirology 2013;18(7):1056–1062.
    OpenUrlPubMed
  15. 15.↵
    1. Llor C,
    2. Moragas A,
    3. Miravitlles M.
    , ESAB study. Usefulness of a patient symptom diary card in the monitoring of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Int J Clin Pract 2012;66(7):711–717.
    OpenUrlPubMed
  16. 16.↵
    1. Murray MP,
    2. Turnbull K,
    3. Macquarrie S,
    4. Hill AT
    . Assessing response to treatment of exacerbations of bronchiectasis in adults. Eur Respir J 2009;33(2):312–318.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Allegra L,
    2. Blasi F,
    3. Diano P,
    4. Cosentini R,
    5. Tarsia P,
    6. Confalonieri M,
    7. et al
    . Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease. Respir Med 2005;99(6):742–747.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Kapur N,
    2. Masters IB,
    3. Chang AB
    . Exacerbations in noncystic fibrosis bronchiectasis: clinical features and investigations. Respir Med 2009;103(11):1681–1687.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Kapur N,
    2. Masters IB,
    3. Morris PS,
    4. Galligan J,
    5. Ware R,
    6. Chang AB
    . Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis. Pediatr Pulmonol 2012;47(1):68–75.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Goeminne PC,
    2. Vandooren J,
    3. Moelants EA,
    4. Decraene A,
    5. Rabaey E,
    6. Pauwels A,
    7. et al
    . The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis. Respirology 2014;19(2):203–210.
    OpenUrlPubMed
  21. 21.↵
    1. Abbott J,
    2. Holt A,
    3. Morton AM,
    4. Hart A,
    5. Milne G,
    6. Wolfe SP,
    7. Conway SP
    . Patient indicators of a pulmonary exacerbation: preliminary reports from school aged children map onto those of adults. J Cyst Fibros 2012;11(3):180–186.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Hermansson LM,
    2. Bodin L,
    3. Eliasson AC
    . Intra- and inter-rater reliability of the assessment of capacity for myoelectric control. J Rehabil Med 2006;38(2):118–123.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Whatman C,
    2. Hing W,
    3. Hume P
    . Physiotherapist agreement when visually rating movement quality during lower extremity functional screening tests. Phys Ther Sport 2012;13(2):87–96.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Miles A,
    2. Huckabee ML
    . Intra- and inter-rater reliability for judgement of cough following citric acid inhalation. Int J Speech Lang Pathol 2013;15(2):209–215.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Allingame S,
    2. Williams T,
    3. Jenkins S,
    4. Tucker B
    . Accuracy and reliability of physiotherapists in the interpretation of tape-recorded lung sounds. Aust J Physiother 1995;41(3):179–184.
    OpenUrlPubMed
  26. 26.↵
    1. Morrow B,
    2. Angus L,
    3. Greenhough D,
    4. Hansen A,
    5. Olivier O,
    6. Shillington L,
    7. et al
    . The reliability of identifying bronchial breathing by auscultation. Int J Ther Rehabil 2010;17(2):69–75.
    OpenUrl
  27. 27.↵
    1. Brooks D,
    2. Thomas J
    . Interrater reliability of auscultation of breath sounds among physical therapists. Phys Ther 1995;75(12):1082–1088.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Juurlink DN,
    2. Detsky AS
    . Kappa statistic. CMAJ 2005;173(1):16.
    OpenUrlFREE Full Text
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords